Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-208"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-24"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20101124.15.3-208"2
lpv:hasSubsequent	lp_eu:2010-11-24-Speech-3-9522
lpv:speaker	lp:Louis Michel2
lpv:spokenAs	member; Delegation to the Cariforum — EU Parliamentary Committee (2010-06-16--2014-06-30)3 unknown; Mouvement Réformateur (2009-07-14--2014-06-30)3 member_of_the_bureau; ALDE (2009-07-20--2014-06-30)3 member; LIBE (2009-07-16--2012-01-18)3 substitute; DEVE (2009-07-16--2012-01-18)3 co-president; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-17--2014-06-30)3 member; Conference of Delegation Chairs (2009-09-17--2014-06-30)3
lpv:translated text	"In order to safeguard the rights and interests of patients, the latter should be able to avail themselves of good quality, objective, reliable and non-promotional information on medicines. If we wish to protect health, pharmaceutical leaflets must be as clear and comprehensive as possible, and must satisfy basic quality criteria. With this same concern to protect patients and provide information to the general public, we must promote the easiest possible access to information, in particular by summarising the characteristics of the product and providing a leaflet for these in both electronic and printed form. That is why we will have to ensure the availability of certified and registered websites offering considerable amounts of independent, objective and non-promotional information."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph